Global Extracorporeal Membrane Oxygenation (ECMO) Devices Market will grow to US$ 812.09 Mn by 2028 at a CAGR of 13.02% over the forecast period
Global Extracorporeal Membrane Oxygenation (ECMO) Devices Market will grow to US$ 812.09 Mn by 2028 at a CAGR of 13.02% over the forecast period - says Absolute Markets Insights
PR87308
PUNE, India, Dec. 17, 2020 /PRNewswire=KYODO JBN/ --
- The global extracorporeal membrane oxygenation (ECMO) devices market was
estimated to be US$ 308.10 million in 2019.
Request for Sample Copy of This Report@
https://www.absolutemarketsinsights.com/request_sample.php?id=758
- The need for respiratory care has grown in recent times owing to various
contributing factors for lung disorders. Along with traditional disorders,
cases related to newer disorders have observed to grow over the years. The
severity of these disorders on the patient has been seen to be varying. Cases
with higher severity have been notable for the deployment of market offerings
in an attempt to help with oxygenation processes for patients. The use of the
devices is observed to facilitate the reduction of stress on the lungs of the patient.
- Demand for Extracorporeal Membrane Oxygenation (ECMO) Devices Market
offerings has grown more recently owing to the application of devices provided
from the market in cases of high severity due the (COVID-19). Medical
facilities are advised to utilize Extracorporeal Membrane Oxygenation (ECMO)
devices in assisting patients for vital lung operations for short duration in
order to limit the potential for risks for the internal systems of the patient.
Enquiry Before Buying @
https://www.absolutemarketsinsights.com/enquiry_before_buying.php?id=758
- North America was observed to be the significant Extracorporeal Membrane
Oxygenation (ECMO) Devices Market share holder in the market for the recent
scenario. The revenue generated from the region of Asia Pacific is expected to
grow at the fastest growth rate over the forecast period primarily due to the
increasing investments towards manufacturing and development of market
offerings from companies situated in the region. In addition to this, growing
focus towards collaborative initiatives for product development, production and
other processes are expected to have a propulsive effect towards the growth of
the market.
- Some of the players operating in the Extracorporeal Membrane Oxygenation
(ECMO) devices market are ALung Technologies, Inc., ORMED Medizintechnik GmbH &
Co. KG, CytoSorbents Europe GmbH, EUROSETS, LivaNova PLC (CardiacAssist, Inc),
MC3 Cardiopulmonary, Medtronic, NIPRO, and Terumo Cardiovascular Systems
Corporation, among others.
Get Full Information of this premium report@
About Us:
Absolute Markets Insights strives to be your main man in your business
resolve by giving you insight into your products, market, marketing,
competitors, and customers. Visit …
[https://www.absolutemarketsinsights.com/about_us]
Contact Us:
Email id: sales@absolutemarketsinsights.com
Contact Name: Shreyas Tanna
Phone: +91-740-024-2424
Logo: https://mma.prnewswire.com/media/831667/Absolute_Market_Insights_Logo.jpg
Photo: https://mma.prnewswire.com/media/1387247/AMI_ECMO_Devices_Mkt.jpg
Source: Absolute Markets Insights
本プレスリリースは発表元が入力した原稿をそのまま掲載しております。また、プレスリリースへのお問い合わせは発表元に直接お願いいたします。
このプレスリリースには、報道機関向けの情報があります。
プレス会員登録を行うと、広報担当者の連絡先や、イベント・記者会見の情報など、報道機関だけに公開する情報が閲覧できるようになります。